Stay updated with breaking news from Ihc Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amin Nassar, MD, and Elias Bou Farhat, MD, spotlight a study evaluating the accuracy and sensitivity of NGS mutation signature in assessing MMR status vs IHC testing.
Expert oncologist Ian Hagemann, MD, PhD, shares insight into the process of making a differential diagnosis of low-grade serous ovarian cancer in light of adjacent disease and available IHC testing.
Broadening their conversation, expert oncologists define the treatment algorithm for patients diagnosed with colorectal cancer.